Barriers to adherence among adolescents with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 16, Issue 1, 2010, Pages 36-41

  Greenley, Rachel Neff ^a   Stephens, Mike ^a   Doughty, Alyssa ^a   Raboin, Tara ^a   Kugathasan, Subra ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Compliance issues in IBD; Pediatrics; Psychosocial aspects of IBD

Indexed keywords

AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; IMMUNOMODULATING AGENT; MINERAL; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; STEROID; VITAMIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; DEMOGRAPHY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DRUG WITHDRAWAL; ENTERITIS; FAMILY; FATHER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOTHER; MULTIMETHOD STUDY; PARENT; PATIENT COMPLIANCE; PEDIATRICIAN; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; SELF CONCEPT; TIME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADOLESCENT PSYCHOLOGY; CHILD; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; TIME FACTORS;

EID: 74049162771     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20988     Document Type: Article

References (13)

1. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525-531.
2. Rapoff MA. Adherence to Pediatric Medical Regimens. New York: Kluwer Academic; 1999.
3. Holmbeck GN, Greenley RN, Franks EB. Developmental issues and considerations in research and practice. In: Kazdin AE and Weisz JP, eds. Evidence-Based Psychotherapy for Children and Adolescents. New York: Guilford Press; 2003:21-41.
4. LaGreca AM, Bearman KJ. Adherence to pediatric treatment regimens. In: Roberts MC, ed. Handbook of Pediatric Psychology. 3rd ed. New York: Guilford Press; 2003:119-140.
5. Hommel KA, Davis CM, Baldassano RN. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:589-593.
6. Hommel KA, Davis CM, Baldassano RN. Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol. 2008;33:867-874.
7. Mackner LM, Crandall,WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:1006-1012.
8. Oliva-Hemker MM, Abadom V, Cuffari C, et al. Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease. J Pediatr Gastroenterol Nut. 2007;44:180-184.
9. Ooi CY, Bohane TD, Lee D, et al. Thiopurine metabolite monitoring in pediatric inflammatory bowel disease. Aliment Pharmacol Ther. 2007;25:941-947.
10. Drotar DD. Overcoming barriers to treatment adherence in minorities and persons living in poverty. Presentation at National Institutes of Health Investigators funded under RFA; 2006.
11. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
12. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929-2933.
13. Hommel KA, Denson LA, Crandall WV, et al. Behavioral functioning and treatment adherence in pediatric inflammatory bowel disease: review and recommendations for practice. Gastroenterol Hepatol. 2008;785-791.